RoHS covers in-scope medical devices and category 9 monitoring and control instruments, with separate application dates, phthalate timing, spare-part rules, and Annex IV exemptions.
This page helps build a RoHS release record for medical devices, in vitro diagnostic devices, monitoring instruments, and industrial monitoring and control instruments.
RoHS covers medical devices that are also electrical and electronic equipment (EEE), while category 9 covers monitoring and control instruments. For in-scope equipment, identify the exact subcategory and placing-on-the-market date, apply the homogeneous-material restrictions, check any Annex III or Annex IV exemption, and retain the CE declaration and technical documentation. The original six substance restrictions have applied since 22 July 2014, 22 July 2016, or 22 July 2017 depending on the subcategory; the four phthalate restrictions have applied to these categories since 22 July 2021.
1
Section 1
Scope and application dates for categories 8 and 9
Directive 2011/65/EU lists as medical devices and category 9 as monitoring and control instruments, including industrial monitoring and control instruments. Category alone does not settle scope. The product must first be EEE within the Directive: equipment dependent on electric currents or electromagnetic fields to fulfil at least one intended function and designed for use at no more than 1,000 volts AC or 1,500 volts DC. Article 2 exclusions must then be checked; active implantable medical devices are expressly excluded, as are several other product groups such as equipment necessary to protect Member States' essential security interests and equipment specifically designed and installed as part of excluded equipment. The latter must function only as part of that equipment and be replaceable only by the same specifically designed equipment.
For in-scope equipment, the restriction in Article 4(1) applies by subcategory date. Identify whether the product is a general medical device, an in vitro diagnostic medical device, a general monitoring or control instrument, or an industrial monitoring and control instrument before choosing the date.
The core substance restrictions apply to medical devices and general monitoring and control instruments placed on the market from 22 July 2014, in vitro diagnostic medical devices from 22 July 2016, and industrial monitoring and control instruments from 22 July 2017. Products outside old RoHS scope but inside RoHS 2 had a separate open-scope date of 22 July 2019, unless a more specific or 9 date applied.
Document why the product is EEE, check every relevant Article 2 exclusion, and then classify the finished EEE against Annex I before reviewing exemptions or supplier evidence.
Do not import a Medical Device Regulation (MDR) or In Vitro Diagnostic Medical Devices Regulation (IVDR) class directly into RoHS. RoHS is a product category, not medical-device risk class I, IIa, IIb, or III, and RoHS Article 3 still contains its own cross-referenced medical-device definitions.
Record the exact placing-on-the-market date because Article 4 treats , in vitro diagnostic devices, category 9, and industrial monitoring instruments differently.
Apply Annex II maximum concentration values at homogeneous-material level: 0.1% for lead, mercury, hexavalent chromium, PBB, PBDE, DEHP, BBP, DBP, and DIBP, and 0.01% for cadmium.
Binding source for the EEE definition and voltage limits, Article 2 exclusions, Annex I categories, Article 4 application dates, and Annex II homogeneous-material concentration limits.
Binding source for DEHP, BBP, DBP, and DIBP limits and later application to medical and monitoring equipment.
from 22 July 2021
2
Section 2
What changes for phthalates and spare parts
The four phthalates added by Delegated Directive (EU) 2015/863 have their own timing for this equipment family. DEHP, BBP, DBP, and DIBP restrictions apply to medical devices, including in vitro medical devices, and to monitoring and control instruments, including industrial monitoring instruments, from 22 July 2021.
Spare parts need a dated analysis rather than a blanket exemption. Annex II excludes the four phthalate restrictions for cables and spare parts used for repair, reuse, updating, or capacity upgrading of medical devices and monitoring and control instruments placed on the market before 22 July 2021. Article 4 also contains older category-specific spare-part provisions for the six original RoHS substances and reused parts in auditable closed-loop business-to-business systems.
Separate the original six restricted substances from the four phthalates because the legal dates and spare-part wording differ.
For service parts, record the original equipment category, original placing-on-market date, part source, reuse or repair purpose, and whether the part is a finished EEE or only a spare part.
Do not describe a spare-part route as generally available unless the date, category, substance, and use condition all match the directive text.
Binding source for the phthalate transition rule for medical devices and monitoring and control instruments.
medical devices, including in vitro medical devices
3
Section 3
Use Annex IV carefully, not as a product-wide waiver
Medical and monitoring equipment may use ordinary Annex III exemptions where the entry applies, and may also use Annex IV entries that are specific to medical devices and monitoring and control instruments. Those entries are application-specific, not company-wide or product-wide. A compliant record should therefore identify the exact material or component, restricted substance, exemption entry, category, expiry date, and renewal status.
Annex IV includes entries for applications such as ionising-radiation detectors, X-ray tubes, MRI-related uses, electrochemical sensors, industrial monitoring sensors, recovered spare parts, and certain DEHP uses. The entries do not share one expiry date, and an old date in the Annex does not by itself show that a renewal is pending or that the exemption remains usable. Check the exact consolidated entry, the Commission's current exemptions list, and any renewal decision for that entry before release.
Check Annex III first for general EEE exemptions and Annex IV for medical or monitoring-specific applications.
Treat every exemption as a narrow application statement tied to one substance, use, category, and expiry date.
Track renewal requests early: Article 5 requires renewal applications no later than 18 months before expiry. A pending request for a new exemption does not permit non-compliant EEE to be placed on the market; an existing exemption for which a timely renewal request was submitted remains valid until the Commission decides.
Commission implementation page for exemption procedure, reassessment factors, and current timing expectations.
Exemptions are limited in time
4
Section 4
Evidence package for release and market surveillance
For and 9 products, the evidence file should let a reviewer trace the classification, date decision, restricted-substance assessment, exemptions, supplier inputs, and CE declaration without relying on project memory. Manufacturers must draw up technical documentation, complete the conformity assessment route, draw up the EU declaration of conformity, affix the CE marking on finished EEE, and keep the technical documentation and declaration for 10 years after placing the EEE on the market.
EN IEC 63000:2018 is the harmonised standard reference published for RoHS technical documentation. It supports a structured evidence set for materials, components, and EEE; it does not supersede the need to map the specific device, instrument, spare part, supplier declaration, lab test, or exemption to the exact RoHS requirement.
Keep a dated category memo, bill of materials (BOM) or material declaration set, restricted-substance matrix, exemption register, supplier declarations, test rationale, technical file, EU declaration of conformity, CE marking evidence, and change-control log.
Importers should verify that the manufacturer completed conformity assessment, drew up technical documentation, supplied CE marking and required documents, and kept required identification and contact information.
Reopen the record when design, materials, suppliers, service parts, intended use, harmonised standards, or Annex III and IV exemption status changes.
Official source publishing EN IEC 63000:2018 as the harmonised standard reference for RoHS technical documentation.
EN IEC 63000:2018
Recommended next step
Build a RoHS category 8 or 9 evidence record
Turn the category, date, substance, exemption, supplier, and CE evidence into one reviewable record for product, regulatory, quality, procurement, and service teams.
Binding source for RoHS categories 8 and 9, Article 4 application dates, Article 5 exemptions, economic-operator duties, Annex II limits, Annex III, Annex IV, and the EU declaration model.
Binding source for the EEE definition and voltage limits, Article 2 exclusions, Annex I categories, Article 4 application dates, and Annex II homogeneous-material concentration limits.
Binding source for Article 4 cable, spare-part, reused-part, and closed-loop provisions.
Show 2 more
Binding source for Article 5 exemption criteria, renewal timing, Annex III, and Annex IV entries.
Binding source for manufacturer, importer, distributor, CE marking, declaration, presumption of conformity, and retention duties.